Merck & Co and Ackermans & van Haaren are among the limited partners for the $68m first close of Quadria Capital's healthcare technology fund.
India-based venture capital firm Quadria Capital has raised $68m for the first close of its second HealthQuad fund, including commitments from pharmaceutical company Merck & Co and conglomerate Ackermans & van Haaren (AvH).
Other commitments came from Teachers Insurance and Annuity Association of America (TIAA) and state-owned investment agencies Sidbi and Swedfund. Quadria made its initial close of its first fund at just under $10m in June 2016.
The firm’s portfolio includes Medikabazaar, Technology Healthcare Big Data Analytics, Strand Asian…
